Thermage FLX® is the latest iteration of the popular radiofrequency-based Thermage skin tightening system from Solta Medical, a division of Bausch Health (Bothell, Wash.).
Sponsored by Thermi, an Almirall company
As women grow older, the effects of childbirth and menopausal issues can lead to vaginal laxity, urine leakage, difficulty achieving orgasms and dryness. These and other gynecological health concerns often combine with the normal aging process to produce a range of emotional and physical challenges for women. Plus, medical and aesthetic problems in this area have traditionally involved some kind of a surgical procedure, with the associated discomfort and downtime.
In the Asia-Pacific (APAC) region, the medical aesthetic market continues to grow faster than any other area in the world. Throughout the region, and especially in China with the rise of its wealthy middle class, people have grown more aware of beauty issues, becoming well-informed about aesthetic treatments via the Internet and social media, and actively seeking out procedures. Meanwhile, the physician’s armamentarium has similarly expanded to include non- and minimally invasive solutions that appeal to more people.
Nearly 3,000 of the industry's top aesthetic physicians and related professionals descended upon Las Vegas, Nev., from July 5 - 8, 2018, to experience the highly anticipated 12th annual installment of The Aesthetic Show (TAS). Taking place at the Wynn Resort & Casino, this leading scientific conference offered four days of unrivaled educational sessions, workshops and hands-on training.
As a perennial highlight of The Aesthetic ShowTM (TAS), the Certified Aesthetic Consultant (CAC) Fast Track Program is the only current and continuously updated certification program in the medical aesthetic industry. This highly-structured and interactive daylong educational course delivers the most comprehensive information and guidacne on running a successful practice in today's highly competitive market.
As demand for energy-based anti-aging procedures continues to rise, practitioners are faced with choosing from a wide array of aesthetic platforms and devices. Five experts share insights on how to differentiate.
Microneedling has come of age in the medical aesthetic arena as SkinPen® from Bellus Medical (Addison, Texas) recently announced that it is the first and only microneedling system to receive a De Novo clearance as a Class II medical device by The Food and Drug Administration (FDA). This designation grants the company clearance and marketing authorization for the device, which is intended to improve the appearance of facial acne scars in adults aged 22 years or older. This clearance was based on the FDA’s recently codified language regarding aesthetic uses of microneedling.
A global revolution is taking hold throughout the medical aesthetic field. Increasingly, regenerative and cell-based techniques are starting to reduce or replace the need for more invasive surgery, drug or chemical-based therapies.
As the fastest growing, most diverse market for aesthetic medicine, the Asia-Pacific (APAC) region is experiencing an upsurge in new clinics and spas, increased equipment sales and robust growth in non-invasive procedure volume. This ongoing progression, and recent technological advances have also driven an expansion of educational conferences in the region.
DermapenWorld (Sydney, Australia) is setting a new benchmark in microneedling technology with the recent release of Dermapen™ 4. Featuring an advanced 16-needle cartridge design for drag-free penetration with regulated suction release, Dermapen’s 33-gauge stainless steel gamma sterilized needles create 1,920 puncture channels per second.